HB 1416Session 2025
Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.
Progress
- Introduced
- In committee
- Passed House
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
Legislative history
-
Senate
Second Reading referred to Health and Human Services Committee then to Appropriations Committee
-
Senate
First Reading
-
House
Engrossed, signed, to Senate
-
House
Referred for engrossment
-
House
Third Reading, Measure passed: Ayes: 90 Nays: 7
-
House
Title stricken
-
House
Amended
-
House
Coauthored by Representative(s) Fugate
-
House
General Order
-
House
CR; Do Pass, amended by committee substitute Health and Human Services Oversight Committee
-
House
Authored by Senator Rosino (principal Senate author)
-
House
Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
-
House
Referred to Public Health
-
House
Second Reading referred to Health and Human Services Oversight
-
House
Authored by Representative West (Josh)
-
House
First Reading